MLANA and neoplasm with perivascular epithelioid cell differentiation: That study concluded that PNL2 is a reliable biomarker for the diagnosis of uterine PEComa, with comparable sensitivity and specificity to HMB45, and greater sensitivity and extent of staining when compared with Melan-A.